Market open
Zimmer Biomet/$ZBH
13:30
21:10
04:45
12:25
20:00
1D1W1MYTD1Y5YMAX
About Zimmer Biomet
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Ticker
$ZBH
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
17,000
ISIN
US98956P1021
Website
Zimmer Biomet Metrics
BasicAdvanced
$19B
21.63
$4.51
0.78
$0.96
0.98%
Price and volume
Market cap
$19B
Beta
0.78
52-week high
$122.17
52-week low
$89.92
Average daily volume
2.6M
Dividend rate
$0.96
Financial strength
Current ratio
2.436
Quick ratio
1.271
Long term debt to equity
54.117
Total debt to equity
59.058
Dividend payout ratio (TTM)
21.28%
Interest coverage (TTM)
6.61%
Management effectiveness
Return on assets (TTM)
4.42%
Return on equity (TTM)
7.32%
Valuation
Price to earnings (TTM)
21.627
Price to revenue (TTM)
2.552
Price to book
1.56
Price to tangible book (TTM)
-18.18
Price to free cash flow (TTM)
17.374
Dividend yield (TTM)
0.98%
Forward dividend yield
0.98%
Growth
Revenue change (TTM)
3.30%
Earnings per share change (TTM)
-2.33%
3-year revenue growth (CAGR)
3.77%
3-year earnings per share growth (CAGR)
62.92%
What the Analysts think about Zimmer Biomet
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Zimmer Biomet stock.
Zimmer Biomet Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Zimmer Biomet Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Zimmer Biomet News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Zimmer Biomet stock?
Zimmer Biomet (ZBH) has a market cap of $19B as of May 14, 2025.
What is the P/E ratio for Zimmer Biomet stock?
The price to earnings (P/E) ratio for Zimmer Biomet (ZBH) stock is 21.63 as of May 14, 2025.
Does Zimmer Biomet stock pay dividends?
Yes, the Zimmer Biomet (ZBH) stock pays dividends to shareholders. As of May 14, 2025, the dividend rate is $0.96 and the yield is 0.98%. Zimmer Biomet has a payout ratio of 21.28% on a trailing twelve-month basis.
When is the next Zimmer Biomet dividend payment date?
The next Zimmer Biomet (ZBH) dividend payment date is unconfirmed.
What is the beta indicator for Zimmer Biomet?
Zimmer Biomet (ZBH) has a beta rating of 0.78. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.